Block Copolymer Based Composition of Epigallocatechin-3-gallate with Improved Oral Bioavailability as a Way to Increase its Therapeutic Activity

Evgueni Klinski¹, Alexandre Semov¹, Xu Yan¹, Valery Alakhov^1*, Ekaterina Muyzhnek² and Vsevolod Kiselev³

¹Supratek Pharma Inc. Montreal, Quebec, Canada, E-mail: Evgueniklinski125@gmail.com

²MiraxBioPharma, Moscow, Russia, E-mail: Evgueniklinski125@gmail.com

³National Research Centre, “Kurchatov Institute”, Moscow, Russia, E-mail: Evgueniklinski125@gmail.com

^*Corresponding Author: Valery Alakhov, Supratek Pharma Inc., Montreal, Quebec, Canada, Tel: 1-514-422-9191, Fax: 1-514-422-9410 Email: